These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 34279600)

  • 1. Health Maintenance Consensus for Adults With Inflammatory Bowel Disease.
    Syal G; Serrano M; Jain A; Cohen BL; Rieder F; Stone C; Abraham B; Hudesman D; Malter L; McCabe R; Holubar S; Afzali A; Cheifetz AS; Gaidos JKJ; Moss AC
    Inflamm Bowel Dis; 2021 Oct; 27(10):1552-1563. PubMed ID: 34279600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SURGICAL MANAGEMENT OF ADULT CROHN'S DISEASE AND ULCERATIVE COLITIS PATIENTS: A CONSENSUS FROM THE BRAZILIAN ORGANIZATION OF CROHN'S DISEASE AND COLITIS (GEDIIB).
    Zabot GP; Cassol OS; Quaresma AB; Gonçalves Filho FA; Baima JP; Imbrizi M; Rolim AS; Carmo AMD; Alves Junior AJT; Santos CHMD; Sobrado Junior CW; Miranda EF; Albuquerque IC; Souza MM; Kaiser Junior RL; Parra RS; Kotze PG; Saad-Hossne R
    Arq Gastroenterol; 2023; 59(suppl 1):1-19. PubMed ID: 36995887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining the Roles of Inflammatory Bowel Disease Clinical Pharmacists in the United States: A Systematic Review and National RAND/UCLA Consensus.
    Bhat S; Lyu R; Agarwal M; Becker M; Bloomfeld R; Bruining DH; Cohen BL; Ivanov M; Leighton JA; Stewart AP; Trocke L; Tse SS; Ungaro RC; Vaughn BP; Regueiro M; Sokn E; Rieder F
    Inflamm Bowel Dis; 2024 Jun; 30(6):950-959. PubMed ID: 37650888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus.
    Macaluso FS; Caprioli F; Benedan L; Bezzio C; Caporali R; Cauli A; Chimenti MS; Ciccia F; D'Angelo S; Fantini MC; Festa S; Iannone F; Lubrano E; Mariani P; Papi C; Provenzano G; Pugliese D; Rispo A; Saibeni S; Salvarani C; Variola A; Zenga M; Armuzzi A; Orlando A; Gerli R
    Autoimmun Rev; 2024 May; 23(5):103533. PubMed ID: 38521214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRAZILIAN CONSENSUS ON THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASES IN PEDIATRIC PATIENTS: A CONSENSUS OF THE BRAZILIAN ORGANIZATION FOR CROHN'S DISEASE AND COLITIS (GEDIIB).
    Lomazi EA; Oba J; Rodrigues M; Marmo MCDR; Sandy NS; Sdepanian VL; Imbrizi M; Baima JP; Magro DO; Albuquerque IC; Zabot GP; Cassol OS; Saad-Hossne R
    Arq Gastroenterol; 2023; 59(suppl 1):85-124. PubMed ID: 36995890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. British Dietetic Association consensus guidelines on the nutritional assessment and dietary management of patients with inflammatory bowel disease.
    Lomer MCE; Wilson B; Wall CL
    J Hum Nutr Diet; 2023 Feb; 36(1):336-377. PubMed ID: 35735908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases.
    Papamichael K; Cheifetz AS; Melmed GY; Irving PM; Vande Casteele N; Kozuch PL; Raffals LE; Baidoo L; Bressler B; Devlin SM; Jones J; Kaplan GG; Sparrow MP; Velayos FS; Ullman T; Siegel CA
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1655-1668.e3. PubMed ID: 30928454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comprehensive Literature Review and Expert Consensus Statement on Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease.
    Cheifetz AS; Abreu MT; Afif W; Cross RK; Dubinsky MC; Loftus EV; Osterman MT; Saroufim A; Siegel CA; Yarur AJ; Melmed GY; Papamichael K
    Am J Gastroenterol; 2021 Oct; 116(10):2014-2025. PubMed ID: 34388143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canadian Consensus Statements on the Transition of Adolescents and Young Adults with Inflammatory Bowel Disease from Pediatric to Adult Care: A Collaborative Initiative Between the Canadian IBD Transition Network and Crohn's and Colitis Canada.
    Fu N; Bollegala N; Jacobson K; Kroeker KI; Frost K; Afif W; El-Matary W; Fowler SA; Griffiths AM; Huynh HQ; Jantchou P; Karimuddin A; Nguyen GC; Otley AR; Pears C; Seow CH; Toulany A; Tersigni C; Tignanelli J; Marshall JK; Boctor M; Hansen T; Pattni C; Wong A; Benchimol EI
    J Can Assoc Gastroenterol; 2022 Jun; 5(3):105-115. PubMed ID: 35669843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) and the Association of Crohn's Disease and Ulcerative Colitis Patients (ACCU) in the management of psychological problems in Inflammatory Bowel Disease patients.
    Barreiro-de Acosta M; Marín-Jiménez I; Panadero A; Guardiola J; Cañas M; Gobbo Montoya M; Modino Y; Alcaín G; Bosca-Watts MM; Calvet X; Casellas F; Chaparro M; Fernández Salazar L; Ferreiro-Iglesias R; Ginard D; Iborra M; Manceñido N; Mañosa M; Merino O; Rivero M; Roncero O; Sempere L; Vega P; Zabana Y; Mínguez M; Nos P; Gisbert JP
    Gastroenterol Hepatol; 2018 Feb; 41(2):118-127. PubMed ID: 29275001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colitis and Crohn's Foundation (India) consensus statements on use of 5-aminosalicylic acid in inflammatory bowel disease.
    Sood A; Ahuja V; Midha V; Sinha SK; Pai CG; Kedia S; Mehta V; Bopanna S; Abraham P; Banerjee R; Bhatia S; Chakravartty K; Dadhich S; Desai D; Dwivedi M; Goswami B; Kaur K; Khosla R; Kumar A; Mahajan R; Misra SP; Peddi K; Singh SP; Singh A
    Intest Res; 2020 Oct; 18(4):355-378. PubMed ID: 32646198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SECOND BRAZILIAN CONSENSUS ON THE MANAGEMENT OF CROHN'S DISEASE IN ADULTS: A CONSENSUS OF THE BRAZILIAN ORGANIZATION FOR CROHN'S DISEASE AND COLITIS (GEDIIB).
    Imbrizi M; Baima JP; Azevedo MFC; Andrade AR; Queiroz NSF; Chebli JMF; Chebli LA; Argollo MC; Sassaki LY; Parra RS; Quaresma AB; Vieira A; Damião AOMC; Moraes ACDS; Flores C; Zaltman C; Vilela EG; Morsoletto EM; Gonçalves Filho FA; Penna FGCE; Santana GO; Zabot GP; Parente JML; Costa MHM; Zerôncio MA; Machado MB; Cassol OS; Kotze PG; Fróes RSB; Miszputen SJ; Ambrogini Junior O; Saad-Hossne R; Coy CSR
    Arq Gastroenterol; 2023; 59(suppl 1):20-50. PubMed ID: 36995888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative Dietary Therapy in Inflammatory Bowel Disease.
    Adamina M; Gerasimidis K; Sigall-Boneh R; Zmora O; de Buck van Overstraeten A; Campmans-Kuijpers M; Ellul P; Katsanos K; Kotze PG; Noor N; Schäfli-Thurnherr J; Vavricka S; Wall C; Wierdsma N; Yassin N; Lomer M
    J Crohns Colitis; 2020 May; 14(4):431-444. PubMed ID: 31550347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified Delphi Process for the Development of Choosing Wisely for Inflammatory Bowel Disease.
    Nguyen GC; Boland K; Afif W; Bressler B; Jones JL; Weizman AV; Fowler S; Halder S; Huang VW; Kaplan GG; Khanna R; Murthy SK; Ruel J; Seow CH; Targownik LE; Chawla T; Guimaraes L; Fernandes A; Saleh S; Melmed GY
    Inflamm Bowel Dis; 2017 Jun; 23(6):858-865. PubMed ID: 28509817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Drug Monitoring to Guide Clinical Decision Making in Inflammatory Bowel Disease Patients with Loss of Response to Anti-TNF: A Delphi Technique-Based Consensus.
    Greuter T; Maillard MH; Juillerat P; Michetti P; Seibold F; Mottet C; Zahnd N; Sauter B; Schoepfer AM; Rogler G; Vavricka SR;
    Digestion; 2020; 101(6):683-691. PubMed ID: 31461706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European Crohn's and Colitis Organisation Topical Review on Transitional Care in Inflammatory Bowel Disease.
    van Rheenen PF; Aloi M; Biron IA; Carlsen K; Cooney R; Cucchiara S; Cullen G; Escher JC; Kierkus J; Lindsay JO; Roma E; Russell RK; Sieczkowska-Golub J; Harbord M
    J Crohns Colitis; 2017 Sep; 11(9):1032-1038. PubMed ID: 28158494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome measures for clinical trials in paediatric IBD: an evidence-based, expert-driven practical statement paper of the paediatric ECCO committee.
    Ruemmele FM; Hyams JS; Otley A; Griffiths A; Kolho KL; Dias JA; Levine A; Escher JC; Taminiau J; Veres G; Colombel JF; Vermeire S; Wilson DC; Turner D
    Gut; 2015 Mar; 64(3):438-46. PubMed ID: 24821616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventive health measures in inflammatory bowel disease.
    Abegunde AT; Muhammad BH; Ali T
    World J Gastroenterol; 2016 Sep; 22(34):7625-44. PubMed ID: 27678347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saudi Arabia consensus guidance for the diagnosis and management of adults with inflammatory bowel disease.
    Mosli MH; Almudaiheem HY; AlAmeel T; Bakkari SA; Alharbi OR; Alenzi KA; Khardaly AM; AlMolaiki MA; Al-Omari BA; Albarakati RG; Al-Jedai AH; Saadah OI; Almadi MA; Al-Bawardy B
    Saudi J Gastroenterol; 2022 Nov; 29(Suppl 1):S1-S35. PubMed ID: 36412460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.